Eli Lilly (LLY) Current Taxes (2009 - 2025)

Eli Lilly (LLY) has reported Current Taxes for 17 consecutive years, with $9.4 billion the latest figure, recorded in Q3 2025.

• Current Taxes for Q3 2025 came in at $9.4 billion, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $9.4 billion (changed N/A YoY), and the FY2024 annual result was $1.1 billion, changed N/A from the prior year.
• Current Taxes was $9.4 billion for Q3 2025 at Eli Lilly, up from $7.0 billion in the prior quarter.
• Over five years, Current Taxes peaked at $9.4 billion in Q3 2025 and troughed at $126.6 million in Q2 2022.
• Average Current Taxes over 5 years is $2.1 billion, with a median of $791.6 million recorded in 2021.
• Year-over-year, Current Taxes tumbled 82.66% in 2021 and soared 874.57% in 2023.
• Over 5 years, Current Taxes stood at $126.9 million in 2021, then surged by 274.39% to $475.1 million in 2022, then jumped by 316.23% to $2.0 billion in 2023, then tumbled by 43.54% to $1.1 billion in 2024, then soared by 745.97% to $9.4 billion in 2025.
• Per Business Quant data, the three most recent Current Taxes figures were $9.4 billion in Q3 2025, $7.0 billion in Q2 2025, and $6.2 billion in Q1 2025.